Resistance to EGFR inhibitors: molecular determinants and the enigma of head and neck cancer

Oncotarget. 2011 Dec;2(12):894-5. doi: 10.18632/oncotarget.407.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / metabolism
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics*
  • Head and Neck Neoplasms / genetics*
  • Head and Neck Neoplasms / metabolism
  • Humans
  • Protein Kinase Inhibitors / therapeutic use*
  • Receptor-Like Protein Tyrosine Phosphatases, Class 2 / genetics*
  • Sequence Deletion / genetics

Substances

  • Antibodies, Monoclonal
  • Protein Kinase Inhibitors
  • EGFR protein, human
  • ErbB Receptors
  • PTPRS protein, human
  • Receptor-Like Protein Tyrosine Phosphatases, Class 2